International Journal of Pharmaceutical Compounding

A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

LEARN MORE

Join the Partnership for Personalized Prescriptions (P3) Advocacy Effort!

Author(s): Blankenship Cynthia

Issue: Nov/Dec 2017 - Volume 21, Number 6
View All Articles in Issue

Page(s): 468

Join the Partnership for Personalized Prescriptions (P3) Advocacy Effort! Page 1

Download in electronic PDF format for $75

Abstract:

Related Keywords: Cynthia Blankenship, Esq., personalized medication, Drug Quality & Security Act, DQSA, IACP, Partnership for Personalized Prescriptions (P3), patient advocacy

Related Categories: LEGAL, PROFESSIONAL ISSUES

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Join the Partnership for Personalized Prescriptions (P3) Advocacy Effort! Blankenship Cynthia	Nov/Dec 2017 Pg. 468
Veterinary Transdermal Medications: A to Z Davidson Gigi S	Mar/Apr 2003 Pg. 106-113
Molding as Innovative Technology for Personalized Tablet Production Mady Omar Y, Al-Shoubki Adam A, Hagag Youssef, Ibrahim Bakry, Donia Ahmed A	Mar/Apr 2022 Pg. 163-174
PreScription: Drug Quality and Security Act Implementation Subcommittee Hearing Allen Loyd V Jr	Mar/Apr 2018 Pg. 92
Standing Together Fixing the Drug Quality and Security Act Miller David G	Mar/Apr 2015 Pg. 104-106
Final Guidance for Pharmacy Compounding of Human Drug Products Under Section 503A Blankenship Cynthia E	Sep/Oct 2014 Pg. 379-380
Personalized Medicine and Customized Drug Delivery Systems: The New Trend of Drug Delivery and Disease Management Soni Abhishek, Gowthamarajan Kuppusamy, Radhakrishnan Arun	Mar/Apr 2018 Pg. 108-121
Warfarin Personalized Dosage: Re-compounding for a More Suitable Therapy and Better Compliance Pellagatti Tommaso, Ternelli Marco, Frascio Davide, Bettini Ruggero	May/Jun 2017 Pg. 247-250
Efforts to Combat Prescription Drug Abuse Should Not Limit Access to Compounded Pain Medications Gilbert John A	Sep/Oct 2009 Pg. 400-403
Now Is the Time for All Good Compounders to Come to the Aid of Their Profession: What You Do Right Now to Advance Compounding's Advocacy Priorities Can Help Assure Your Profession's Future Brunner Scott	Jul/Aug 2019 Pg. 294-296
The International Academy of Compounding Pharmacists: Government Affairs Lookback on 2017 Accomplishments and Look Ahead at 2018 Initiatives Blankenship Cynthia	Jan/Feb 2018 Pg. 26-28
PreScription: American Pharmacists Assocation and Compounding: New Partnership Reflects Old Ties Menighan Thomas E	Jan/Feb 2010 Pg. 4
IACP Legislative/Regulatory Update International Academy of Compounding Pharmacists	Sep/Oct 2017 Pg. 382-383
Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines Allen Loyd V Jr	Jul/Aug 2016 Pg. 351 View Sample
PostScription: Drug Disposal: Compounding Pharmacists' Involvement in the Prevention of Prescription Drug Misuse and Abuse Williams LaVonn A	Nov/Dec 2011 Pg. 526-527
Profile of a Practice: Ward Drug Company Diabetic Shoppe and Prescription Compounding Center Vail Jane	Jan/Feb 2003 Pg. 21-23
Technology Spotlight: Automated Prescription-Dispensing Systems Allen Loyd V Jr	Nov/Dec 2003 Pg. 458-459
IACP Legislative/Regulatory Update: The International Academy of Compounding Pharmacists Testifies at U.S. House of Representatives' Energy & Commerce Health Subcommittee Pharmacy Compounding Hearing Blankenship Cynthia	Mar/Apr 2018 Pg. 125-126
U.S. Food and Drug Administration Requests for Input on HR 3204 Enactment: The Drug Quality and Security Act of 2013 Miller David G	Jan/Feb 2014 Pg. 35-36
E-Prescription Errors and Their Resolution in a Community Compounding Pharmacy Reed-Kane Dana, Vasquez Kellie, Pavlik Aaron, Pergine Johanna, Sandberg Michelle	Mar/Apr 2014 Pg. 159-161
Return to Top